Intra-Abdominal Pressure Measurement Devices (IPMD) Market Size, Share, Growth, and Industry Analysis, Types (Equipment, Disposables, Others), Applications (Hospitals, Trauma Centers, Ambulatory Surgical Centers, Clinics, Others), and Regional Insights and Forecast to 2035
- Last Updated: 11-April-2026
- Base Year: 2025
- Historical Data: 2021 - 2024
- Region: Global
- Format: PDF
- Report ID: GGI125062
- SKU ID: 30293539
- Pages: 107
Intra-Abdominal Pressure Measurement Devices (IPMD) Market Size
The Global Intra-Abdominal Pressure Measurement Devices (IPMD) Market size was USD 7.70 Billion in 2025 and is projected to reach USD 8.49 Billion in 2026, growing further to USD 9.35 Billion in 2027 and USD 20.29 Billion by 2035, exhibiting a CAGR of 10.17% during the forecast period. Nearly 65% of demand comes from advanced healthcare systems, while about 35% is driven by emerging markets. Adoption rates have increased by approximately 30% due to rising awareness and improved clinical practices.
![]()
The US Intra-Abdominal Pressure Measurement Devices (IPMD) Market is growing steadily, supported by high ICU adoption rates. Around 75% of hospitals use IPMD systems regularly, while nearly 60% of healthcare providers prefer advanced monitoring technologies. Awareness levels exceed 80%, and adoption has increased by about 25% due to improved training and regulatory focus.
Key Findings
- Market Size: Valued at $7.70Bn in 2025, projected to touch $8.49Bn in 2026 to $20.29Bn by 2035 at a CAGR of 10.17%.
- Growth Drivers: 75% ICU usage, 60% monitoring adoption, 55% awareness rise, 30% infrastructure growth.
- Trends: 48% digital devices, 45% disposable demand, 40% minimally invasive use, 30% automation adoption.
- Key Players: C. R. Bard, Inc, ConvaTec Group PLC, Stryker Corporation, Spiegelberg GmbH, Potrero Medical Inc & more.
- Regional Insights: North America 36%, Europe 28%, Asia-Pacific 26%, Middle East & Africa 10% share distribution.
- Challenges: 38% cost concern, 33% handling complexity, 35% training gap, 40% low rural adoption.
- Industry Impact: 60% safety focus, 48% innovation, 45% investment rise, 20% performance improvement.
- Recent Developments: 22% efficiency gain, 20% infection reduction, 18% accuracy improvement, 15% comfort increase.
The Intra-Abdominal Pressure Measurement Devices (IPMD) Market is evolving with a clear focus on patient safety and advanced monitoring. Around 55% of healthcare providers prefer modern devices with automation, while nearly 45% emphasize infection control through disposable components. Increasing ICU demand and clinical awareness are shaping long-term growth.
![]()
Intra-Abdominal Pressure Measurement Devices (IPMD) Market Trends
The Intra-Abdominal Pressure Measurement Devices (IPMD) Market is growing steadily as awareness around critical care monitoring continues to improve. Around 68% of intensive care units now use intra-abdominal pressure monitoring as part of standard patient management. Nearly 52% of abdominal trauma cases require pressure monitoring to prevent complications, showing strong clinical demand. Adoption has increased by approximately 35% across hospitals due to better training and updated treatment protocols.
Technological advancement is also shaping the Intra-Abdominal Pressure Measurement Devices (IPMD) Market. Around 47% of healthcare facilities are shifting toward minimally invasive monitoring devices, reducing patient discomfort and improving accuracy. About 40% of new systems now include digital integration with hospital monitoring platforms, allowing real-time data tracking. In addition, nearly 30% of devices offer automated alerts for pressure changes, helping clinicians respond faster to critical conditions.
Another key trend is the rising focus on infection control. Around 45% of healthcare providers prefer disposable components to reduce contamination risks. Usage of disposable kits has increased by nearly 38% in critical care settings. At the same time, about 55% of hospitals are investing in training programs to improve device handling and accuracy. The Intra-Abdominal Pressure Measurement Devices (IPMD) Market is clearly moving toward safer, more efficient, and more connected monitoring solutions.
Intra-Abdominal Pressure Measurement Devices (IPMD) Market Dynamics
Expansion in critical care infrastructure
The Intra-Abdominal Pressure Measurement Devices (IPMD) Market has strong opportunities due to expanding critical care infrastructure. Around 60% of hospitals are increasing ICU capacity, which directly raises demand for monitoring devices. Nearly 42% of healthcare providers are adopting advanced monitoring systems for better patient outcomes. Additionally, about 36% of new healthcare facilities include IPMD systems as standard equipment, showing a clear opportunity for market growth.
Rising cases of abdominal complications
The market is driven by the increasing number of abdominal conditions requiring monitoring. Around 50% of ICU patients are at risk of intra-abdominal hypertension. Nearly 48% of trauma cases involve abdominal injuries needing pressure monitoring. Awareness among clinicians has improved by about 30%, leading to higher adoption. In addition, around 55% of healthcare professionals consider IPMD essential for managing critical patients.
RESTRAINTS
"Limited awareness in smaller healthcare settings"
Despite growth, awareness remains low in smaller clinics and rural hospitals. Around 40% of healthcare facilities still do not use IPMD devices regularly. Nearly 35% of clinicians lack proper training in pressure monitoring techniques. Adoption rates in smaller centers are below 50%, limiting market expansion. This gap reduces the overall reach of the Intra-Abdominal Pressure Measurement Devices (IPMD) Market.
CHALLENGE
"Cost and device handling complexity"
Device cost and handling complexity remain key challenges. Around 38% of healthcare providers consider IPMD systems expensive compared to basic monitoring tools. Nearly 33% report difficulty in proper device calibration and usage. Training requirements add to operational challenges, with about 28% of staff needing additional training. These factors slow adoption, especially in resource-limited settings.
Segmentation Analysis
The Intra-Abdominal Pressure Measurement Devices (IPMD) Market is segmented by type and application, with each segment playing a key role in demand growth. The global market size was USD 7.70 Billion in 2025 and is projected to reach USD 8.49 Billion in 2026, further growing to USD 9.35 Billion in 2027 and USD 20.29 Billion by 2035, exhibiting a CAGR of 10.17% during the forecast period. Growth is supported by increasing ICU admissions and rising awareness about intra-abdominal pressure monitoring.
By Type
Equipment
Equipment accounts for a significant share of the market, contributing nearly 48% of total demand. Around 60% of hospitals use dedicated monitoring devices for accurate pressure measurement. Advanced equipment with digital interfaces is used in about 42% of critical care units, improving efficiency and data tracking.
Equipment segment held the largest share in the Intra-Abdominal Pressure Measurement Devices (IPMD) Market, accounting for USD 4.07 Billion in 2026, representing 48% of the total market. This segment is expected to grow at a CAGR of 10.17% from 2026 to 2035, driven by technological advancements and hospital adoption.
Disposables
Disposables make up around 37% of the market, with increasing demand due to infection control needs. Nearly 45% of healthcare providers prefer disposable kits to reduce contamination risks. Usage has grown by about 38% in ICU settings, supporting steady market growth.
Disposables segment accounted for USD 3.14 Billion in 2026, representing 37% of the total market. This segment is expected to grow at a CAGR of 10.17% from 2026 to 2035, driven by rising focus on hygiene and safety.
Others
Other components contribute about 15% of the market, including accessories and supporting tools. Around 25% of healthcare facilities use additional components to enhance monitoring accuracy. Demand is growing steadily as hospitals upgrade their monitoring systems.
Others segment accounted for USD 1.28 Billion in 2026, representing 15% of the total market. This segment is expected to grow at a CAGR of 10.17% from 2026 to 2035, supported by complementary device usage.
By Application
Hospitals
Hospitals dominate the application segment, accounting for nearly 55% of total demand. Around 70% of ICU admissions require pressure monitoring, making hospitals the primary users. Adoption of advanced devices is increasing steadily in large healthcare facilities.
Hospitals segment held the largest share, accounting for USD 4.67 Billion in 2026, representing 55% of the total market. This segment is expected to grow at a CAGR of 10.17% from 2026 to 2035, driven by increasing ICU demand.
Trauma Centers
Trauma centers contribute around 18% of the market, with high usage in emergency care. Nearly 50% of trauma patients require monitoring, supporting strong demand. Adoption rates are increasing with better emergency care systems.
Trauma Centers segment accounted for USD 1.53 Billion in 2026, representing 18% of the total market. This segment is expected to grow at a CAGR of 10.17% from 2026 to 2035, supported by rising trauma cases.
Ambulatory Surgical Centers
Ambulatory surgical centers hold about 12% share, with growing demand for post-surgical monitoring. Around 35% of surgeries involve risk of pressure complications, increasing device usage in these settings.
Ambulatory Surgical Centers segment accounted for USD 1.02 Billion in 2026, representing 12% of the total market. This segment is expected to grow at a CAGR of 10.17% from 2026 to 2035, driven by outpatient surgical procedures.
Clinics
Clinics account for nearly 10% of the market, mainly for basic monitoring needs. Around 25% of clinics are adopting IPMD systems, showing gradual growth in smaller healthcare settings.
Clinics segment accounted for USD 0.85 Billion in 2026, representing 10% of the total market. This segment is expected to grow at a CAGR of 10.17% from 2026 to 2035, supported by increasing awareness.
Others
Other applications contribute around 5% of the market, including research and specialty centers. Around 15% of research facilities use IPMD systems for clinical studies, supporting niche demand.
Others segment accounted for USD 0.42 Billion in 2026, representing 5% of the total market. This segment is expected to grow at a CAGR of 10.17% from 2026 to 2035, driven by research activities.
![]()
Intra-Abdominal Pressure Measurement Devices (IPMD) Market Regional Outlook
The Intra-Abdominal Pressure Measurement Devices (IPMD) Market shows strong regional variation driven by healthcare infrastructure and awareness levels. The global market size was USD 7.70 Billion in 2025 and is projected to reach USD 8.49 Billion in 2026, further growing to USD 9.35 Billion in 2027 and USD 20.29 Billion by 2035, exhibiting a CAGR of 10.17% during the forecast period. Around 65% of demand comes from developed healthcare systems, while nearly 35% is driven by emerging markets. Adoption is closely linked to ICU expansion, clinical awareness, and access to advanced monitoring technologies.
North America
North America holds around 36% share in the Intra-Abdominal Pressure Measurement Devices (IPMD) Market due to advanced healthcare systems. Nearly 75% of ICUs use intra-abdominal pressure monitoring as a standard practice. Around 62% of hospitals have adopted digital monitoring devices, improving patient outcomes. Clinical awareness among healthcare professionals exceeds 80%, supporting strong adoption. North America accounted for USD 3.06 Billion in 2026, representing 36% of the total market, and is expected to grow at a CAGR of 10.17% driven by strong healthcare infrastructure and high awareness levels.
Europe
Europe accounts for approximately 28% of the global market share, supported by strict clinical guidelines and safety protocols. Around 70% of critical care units regularly use IPMD systems. Adoption of disposable monitoring kits is close to 50%, improving infection control. Nearly 58% of healthcare providers prefer minimally invasive monitoring techniques. Europe reached USD 2.38 Billion in 2026, representing 28% of the total market, and is expected to grow at a CAGR of 10.17% due to strong regulatory frameworks and advanced medical practices.
Asia-Pacific
Asia-Pacific leads with a share of about 26% driven by rapid healthcare development and increasing ICU capacity. Around 55% of hospitals are adopting advanced monitoring systems, showing strong growth potential. Awareness levels are improving, with nearly 45% of clinicians now using IPMD systems regularly. Healthcare infrastructure expansion has increased device adoption by about 30%. Asia-Pacific reached USD 2.21 Billion in 2026, representing 26% of the total market, and is expected to grow at a CAGR of 10.17% due to rising healthcare investments.
Middle East & Africa
Middle East & Africa account for around 10% of the global market share. Adoption rates are improving, with nearly 40% of hospitals using IPMD devices. Awareness campaigns have increased usage by about 20% in urban areas. Around 35% of healthcare facilities are upgrading to advanced monitoring systems. The region reached USD 0.84 Billion in 2026, representing 10% of the total market, and is expected to grow at a CAGR of 10.17% supported by improving healthcare infrastructure.
List of Key Intra-Abdominal Pressure Measurement Devices (IPMD) Market Companies Profiled
- C. R. Bard, Inc
- ConvaTec Group PLC
- Holtech Medical
- Centurion Medical Products
- Biometrix Ltd
- Stryker Corporation
- Spiegelberg GmbH
- Nutrimedics S.A
- Potrero Medical Inc
- Gaeltec
Top Companies with Highest Market Share
- C. R. Bard, Inc: holds nearly 27% share with strong presence in hospital monitoring solutions.
- ConvaTec Group PLC: accounts for around 19% share driven by disposable product demand.
Investment Analysis and Opportunities in Intra-Abdominal Pressure Measurement Devices (IPMD) Market
Investment in the Intra-Abdominal Pressure Measurement Devices (IPMD) Market is increasing as healthcare systems focus more on critical care monitoring. Around 58% of hospitals are expanding ICU facilities, directly increasing demand for monitoring devices. Nearly 45% of healthcare investments are directed toward advanced patient monitoring technologies. About 38% of medical device companies are investing in innovation to improve accuracy and ease of use.
Emerging markets present strong opportunities, with healthcare infrastructure improving by nearly 30%. Around 50% of investors consider Asia-Pacific a key region for expansion due to rising patient volumes. In addition, nearly 42% of healthcare providers are upgrading to digital monitoring systems. Partnerships between hospitals and device manufacturers have increased by about 25%, improving technology adoption.
Preventive care is also gaining importance, with around 35% of healthcare providers focusing on early detection of complications. This shift is increasing demand for IPMD devices. Around 60% of hospitals now prioritize patient safety monitoring, making this market attractive for long-term investment.
New Products Development
New product development in the Intra-Abdominal Pressure Measurement Devices (IPMD) Market is focused on improving accuracy, ease of use, and patient safety. Around 48% of new devices include digital integration for real-time monitoring. Nearly 40% of manufacturers are developing minimally invasive devices to reduce patient discomfort.
Disposable product innovation is also increasing, with about 45% of new launches focusing on infection control. Around 35% of companies are introducing lightweight and portable devices for easier handling. In addition, nearly 30% of devices now include automated alerts for pressure changes, improving clinical response times.
Training and usability improvements are another focus area, with about 28% of new systems designed for easier operation by medical staff. Around 25% of innovations target improved compatibility with existing hospital systems. These developments reflect a clear shift toward smarter and safer monitoring solutions.
Recent Developments
- C. R. Bard, Inc: introduced advanced monitoring devices with improved accuracy, increasing measurement reliability by nearly 18% in clinical settings.
- ConvaTec Group PLC: launched new disposable kits, reducing infection risk by approximately 20% in ICU environments.
- Stryker Corporation: enhanced device integration with hospital systems, improving data tracking efficiency by about 22%.
- Spiegelberg GmbH: developed minimally invasive devices, reducing patient discomfort by nearly 15% during monitoring procedures.
- Potrero Medical Inc: introduced automated alert systems, improving early detection rates by approximately 17% in critical care units.
Report Coverage
This report covers a detailed analysis of the Intra-Abdominal Pressure Measurement Devices (IPMD) Market, including trends, dynamics, segmentation, regional outlook, and competitive landscape. Around 70% of the analysis focuses on ICU adoption trends and technological advancements. Nearly 65% of hospitals now use IPMD systems, showing strong demand growth.
The report highlights segmentation by type and application, where equipment accounts for about 48% share, disposables 37%, and others 15%. In application, hospitals dominate with around 55%, followed by trauma centers at 18%, ambulatory surgical centers at 12%, clinics at 10%, and others at 5%. These insights help understand demand distribution across healthcare settings.
Regional analysis shows North America leading with 36% share, followed by Europe at 28%, Asia-Pacific at 26%, and Middle East & Africa at 10%. Around 58% of demand comes from developed regions, while emerging markets contribute 42%. The report also covers investment trends, where nearly 45% of companies are focusing on innovation.
Product development trends are also included, showing that around 48% of new devices include digital features, while 45% focus on disposable components. Recent developments highlight improvements in accuracy, safety, and usability ranging between 15% and 22%. The report provides a clear view of market opportunities, challenges, and growth factors.
Intra-Abdominal Pressure Measurement Devices (IPMD) Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 7.70 Billion in 2026 |
|
|
Market Size Value By |
USD 20.29 Billion by 2035 |
|
|
Growth Rate |
CAGR of 10.17% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation |
||
Frequently Asked Questions
-
What value is the Intra-Abdominal Pressure Measurement Devices (IPMD) Market expected to touch by 2035?
The global Intra-Abdominal Pressure Measurement Devices (IPMD) Market is expected to reach USD 20.29 Billion by 2035.
-
What CAGR is the Intra-Abdominal Pressure Measurement Devices (IPMD) Market expected to exhibit by 2035?
The Intra-Abdominal Pressure Measurement Devices (IPMD) Market is expected to exhibit a CAGR of 10.17% by 2035.
-
Who are the top players in the Intra-Abdominal Pressure Measurement Devices (IPMD) Market?
C. R. Bard, Inc, ConvaTec Group PLC, Holtech Medical, Centurion Medical Products, Biometrix Ltd, Stryker Corporation, Spiegelberg GmbH, Nutrimedics S.A, Potrero Medical Inc, Gaeltec
-
What was the value of the Intra-Abdominal Pressure Measurement Devices (IPMD) Market in 2025?
In 2025, the Intra-Abdominal Pressure Measurement Devices (IPMD) Market value stood at USD 7.70 Billion.
Our Clients
Download FREE Sample
Trusted & Certified